Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Seeing the future of bioactive lipid drug targets.

Evans JF, Hutchinson JH.

Nat Chem Biol. 2010 Jul;6(7):476-9. doi: 10.1038/nchembio.394. No abstract available.

PMID:
20559310
2.

Drugs targeting atherosclerosis: current and emerging approaches.

Manolopoulos VG, Tavridou A.

Curr Pharm Des. 2009;15(27):3091-3. No abstract available.

PMID:
19754383
3.

Synthesis and antidyslipidemic activity of chalcone fibrates.

Shukla P, Srivastava SP, Srivastava R, Rawat AK, Srivastava AK, Pratap R.

Bioorg Med Chem Lett. 2011 Jun 1;21(11):3475-8. doi: 10.1016/j.bmcl.2011.03.057. Epub 2011 Mar 31.

PMID:
21515043
4.

An overview of patented small molecule stearoyl coenzyme-A desaturase inhibitors (2009 - 2013).

Powell DA.

Expert Opin Ther Pat. 2014 Feb;24(2):155-75. doi: 10.1517/13543776.2014.851669. Epub 2013 Nov 20. Review.

PMID:
24251719
5.

Artepillin C isoprenomics: design and synthesis of artepillin C analogues as antiatherogenic antioxidants.

Uto Y, Ae S, Hotta A, Terao J, Nagasawa H, Hori H.

Adv Exp Med Biol. 2006;578:113-8. No abstract available.

PMID:
16927679
6.

Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists.

Koura M, Matsuda T, Okuda A, Watanabe Y, Yamaguchi Y, Kurobuchi S, Matsumoto Y, Shibuya K.

Bioorg Med Chem Lett. 2015 Jul 1;25(13):2668-74. doi: 10.1016/j.bmcl.2015.04.080. Epub 2015 May 5.

PMID:
25998501
7.

Nicotinic acid: current status in lipid management and cardiovascular disease prevention.

Whayne TF Jr.

Angiology. 2014 Aug;65(7):557-9. doi: 10.1177/0003319713505897. Epub 2013 Oct 7. No abstract available.

PMID:
24101713
8.

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Khera AV, Rader DJ.

Trends Cardiovasc Med. 2009 Aug;19(6):195-201. doi: 10.1016/j.tcm.2009.12.003. Review.

9.

Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.

Sashidhara KV, Dodda RP, Sonkar R, Palnati GR, Bhatia G.

Eur J Med Chem. 2014 Jun 23;81:499-509. doi: 10.1016/j.ejmech.2014.04.085. Epub 2014 May 14.

PMID:
24871900
10.

Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.

Mokale SN, Elgire RD, Sakle NS, Shinde DB.

Arch Pharm (Weinheim). 2012 Jan;345(1):22-7. doi: 10.1002/ardp.201000229. Epub 2011 Nov 11.

PMID:
22076967
11.

Pirinixic acids: flexible fatty acid mimetics with various biological activities.

Merk D, Zettl M, Steinhilber D, Werz O, Schubert-Zsilavecz M.

Future Med Chem. 2015 Aug;7(12):1597-616. doi: 10.4155/fmc.15.87. Epub 2015 Aug 27. Review.

PMID:
26313377
12.

Discovery and identification of 2-phenylethyl 2,6-dihydroxybenzoate as a natural lipid-lowering lead.

Luo Y, Li G, Li G, Yan J, Yi J, Zhang G.

Planta Med. 2011 Dec;77(18):2047-9. doi: 10.1055/s-0031-1280118. Epub 2011 Aug 19.

PMID:
21858759
13.

Inhibitory Effect on Lipid Absorption and Variability of Chemical Constituents from Capparis sicula subsp. sicula and Capparis orientalis.

Marrelli M, Argentieri MP, Avato P, Menichini F, Conforti F.

Chem Biodivers. 2016 Jun;13(6):755-61. doi: 10.1002/cbdv.201500240. Epub 2016 Jun 1.

PMID:
27138247
14.

Hypolipidemic activity of the chitooligosaccharides from Clanis bilineata (Lepidoptera), an edible insect.

Xia Z, Chen J, Wu S.

Int J Biol Macromol. 2013 Aug;59:96-8. doi: 10.1016/j.ijbiomac.2013.04.017. Epub 2013 Apr 13.

PMID:
23591472
15.

Lipid management in clinical practice.

Jialal I, Devaraj S.

Curr Opin Lipidol. 2009 Aug;20(4):350-2. doi: 10.1097/MOL.0b013e32832dd547. No abstract available.

PMID:
19584593
16.

[Targets of anti-hyperlipidemia drugs].

Li H, Jing X, Deng X, Ouyang D.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jan;38(1):101-8. doi: 10.3969/j.issn.1672-7347.2013.01.019. Review. Chinese.

17.

Discovery of a new class of HMG-CoA reductase inhibitor from Polyalthia longifolia as potential lipid lowering agent.

Sashidhara KV, Singh SP, Srivastava A, Puri A, Chhonker YS, Bhatta RS, Shah P, Siddiqi MI.

Eur J Med Chem. 2011 Oct;46(10):5206-11. doi: 10.1016/j.ejmech.2011.08.012. Epub 2011 Aug 12.

PMID:
21872367
18.

In vitro antihyperlipidemic potential of triterpenes from stem bark of Protorhus longifolia.

Mosa RA, Naidoo JJ, Nkomo FS, Mazibuko SE, Muller CJ, Opoku AR.

Planta Med. 2014 Dec;80(18):1685-91. doi: 10.1055/s-0034-1383262. Epub 2014 Nov 11.

PMID:
25389058
19.

[Effects of puerarin on blood pressure, blood lipid and renal structure of cold-induced hypertensive mice].

Pan ZJ, Yan GL, Wang LP, Xu XX, Pan L.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Nov;27(4):436-8. Chinese. No abstract available.

PMID:
22295519
20.

A comparative study on hypolipidemic activities of high and low molecular weight chitosan in rats.

Zhang J, Zhang W, Mamadouba B, Xia W.

Int J Biol Macromol. 2012 Nov;51(4):504-8. doi: 10.1016/j.ijbiomac.2012.06.018. Epub 2012 Jun 19.

PMID:
22728057

Supplemental Content

Support Center